Abstract
Objective: To study the molecular mechanism of celery seed inhibiting or treating gout by using network pharmacology and molecular docking. Methods: TCMSP database and the network maps were constructed with Cytoscape3.9.0 software. Gout-related targets were collected in GeneCard database and OMIM database, crossed with the main component targets of celery seed and imported into STRING database for protein-protein interaction （protein-protein interaction, PPI） analysis, core targets were obtained, core targets were introduced into DAVID, and GO function enrichment and KEGG pathway enrichment were performed in the database. Finally, AutoDock software was used to verify the key components with key targets. Results: There were 16 main components of celery seeds, 69 common targets. After topological analysis, quercetin, apigenin, luteolin, celery, five core components and 10 key targets of gout TNF, MAPK14, IL4, CXCL8, LYN, PDGFRβ, HCK, VEGFA, ITGA, IL2, were closely involved in inhibiting or treating gout. The results of GO and KEGG analysis showed that the core components of celery seed acted through regulating biological processes such as apoptosis, proliferation and migration, and through PI3K-Akt signaling pathway, IL-17 signaling pathway, MAPK signaling pathway, and NF-κB signaling pathway. The molecular docking results showed that the five core components were closely bound to the 10 key target proteins with high confidence, verifying the accuracy of the network pharmacology prediction results. Conclusion: This study reveals the role of celery seed in inhibiting or treating gout, and lays a foundation for the development of single Chinese herbal medicine and the study of "medicine and food homology" to control metabolic diseases.
Publication Date
4-30-2024
First Page
44
Last Page
51
DOI
10.13652/j.spjx.1003.5788.2024.60009
Recommended Citation
Meijuan, LI; Jun, ZHANG; Yunshu, ZHANG; Qianwei, LI; Na, ZHANG; Mengjiao, LIU; and Renping, ZHANG
(2024)
"Potential molecular mechanism of celery seed in gout treatment of network pharmacology with molecular docking,"
Food and Machinery: Vol. 40:
Iss.
3, Article 6.
DOI: 10.13652/j.spjx.1003.5788.2024.60009
Available at:
https://www.ifoodmm.cn/journal/vol40/iss3/6
References
[1] WHO. World Health Statistics 2022\. （2022-02-10） [2023-12-21]. https://www.who.int/data/gho/publications/world-health-statistics.
[2] LAKE B D. Metabolic disorders: A simplified approach to their diagnosis[M]// Paediatric Pathology. London: Springer-Verlag London Limited, 1996: 839.
[3] KUO C F, GRAINGE M J, ZHANG W, et al. Global epidemiology of gout: Prevalence, incidence and risk factors[J]. Nat Rev Rheumatol, 2015, 11（11）: 649-662.
[4] FEIG D I. Hyperuricemia and hypertension[J]. Advances in Chronic Kidney Disease, 2012, 19（6）: 377-385.
[5] JIN M, YANG F, YANG I, et al. Uric acid, hyperuricemia and vascular diseases[J]. Frontiers in bioscience （Landmark edition）, 2012, 17（2）: 656-669.
[6] WORTMANN R L. Gout and hyperuricemia[J]. Current Opinion in Rheumatology, 2002, 14（3）: 281-286.
[7] BUSSO N, SO A. Gout. Mechanisms of inflammation in gout[J]. Arthritis Research & Therapy, 2010, 12（2）: 206-206.
[8] DALBETH N, CHOI H K, JOOSTEN L A B, et al. Gout[J]. Nature Reviews Disease Primers, 2019, 5（1）: 69.
[9] 徐娜, 陈海生. 治疗痛风药物研究进展[J]. 药学实践杂志, 2013, 31（1）: 14-18.
XU N, CHEN H H. Research progress on drugs for treating gout[J]. Journal of Pharmaceutical Practice, 2013, 31（1）: 14-18.
[10] DOWNER S, BERKOWITZ S A, HARLAN T S, et al. Food is medicine: Actions to integrate food and nutrition into healthcare[J]. BMJ, 2020, 369: m2482.
[11] 单峰, 黄璐琦, 郭娟, 等. 药食同源的历史和发展概况[J]. 生命科学, 2015, 27（8）: 1 061-1 069.
SHAN F, LU Q Q, GUO J, et al. The history and development overview of the homology between medicine and food[J]. Life Sciences, 2015, 27（8）: 1 061-1 069.
[12] 杨光, 苏芳芳, 陈敏. 药食同源起源与展望[J]. 中国现代中药, 2021, 23（11）: 1 851-1 856.
YANG G, SU F F, CHEN M. The origin and prospects of medicinal and edible homology[J]. Chinese Modern Traditional Chinese Medicine, 2021, 23（11）: 1 851-1 856.
[13] LI S, ZHANG B. Traditional Chinese medicine network pharmacology: Theory, methodology and application[J]. Chinese Journal of Natural Medicine, 2013, 11（2）: 110-120.
[14] LONG S D, JI S S, XUE P, et al. Network pharmacology and molecular docking analysis reveal insights into the molecular mechanism of shiliao decoction in the treatment of cancer-associated malnutrition[J]. Frontiers in Nutrition, 2022, 9: 985991.
[15] 史传超. 天然植物功能因子对尿酸代谢酶调控作用机制研究[D]. 广州: 华南理工大学, 2018: 54.
SHI C C. A study on the regulatory mechanism of natural plant functional factors on uric acid metabolism enzymes[D]. Guangzhou: South China University of Technology, 2018: 54.
[16] 李少鹏. 芹菜籽提取物抗急性痛风性关节炎及高尿酸血症的活性研究[D]. 长春: 吉林大学, 2019: 11-13.
LI S P. Anti-gouty arthritis and anti-hyperuricemia properties of celery seed extracts[D]. Changchun: Jilin University, 2019: 11-13.
[17] 徐娜. 芹菜籽活性成分及其抗痛风新药研究[D]. 上海: 第二军医大学, 2012: 37.
XU N. Research on the active ingredients of celery seeds and their new anti gout drugs[D]. Shanghai: Second Military Medical University, 2012: 37.
[18] 仝国辉, 张懿, 张瑶楠, 等. 芹菜籽提取物对高尿酸血症大鼠的影响[J]. 食品科学, 2008, 29（12）: 641-644.
TONG G H, ZHANG Y, ZHANG Y N, et al. The effect of celery seed extract on hyperuricemia rats[J]. Food Science, 2008, 29（12）: 641-644.
[19] 杨娟, 豆佳红, 孙悦龙, 等. 基于网络药理学与分子对接和实验验证探讨费菜抗炎作用的分子机制[J]. 食品工业科技, 2023, 44（4）: 12-21.
YANG J, DOU J H, SUN Y L, et al. Exploring the molecular mechanism of the anti-inflammatory effect of Feicai based on network pharmacology, molecular docking, and experimental verification[J]. Food Industry Technology, 2023, 44（4）: 12-21.
[20] WANG Z, ZHANG H M, GUO Y R, et al. Molecular mechanisms of Biyu decoction as treatment for psoriasis: A network pharmacology and molecular docking study[J]. World Journal of Clinical Cases, 2022, 10（21）: 7 224-7 241.
[21] 凌晓颖, 陶嘉磊, 孙逊, 等. 基于网络药理学的连花清瘟方抗冠状病毒的物质基础及机制探讨[J]. 中草药, 2020, 51（7）: 1 723-1 730.
LING X Y, TAO J L, SUN X, et al. Exploration of the material basis and mechanism of Lianhua Qingwen formula's anti coronavirus effect based on network pharmacology[J]. Chinese Herbal Medicine, 2020, 51（7）: 1 723-1 730.
[22] KAUR T, MADGULKAR A, BHALEKAR M, et al. Molecular docking in formulation and development[J]. Current Drug Discovery Technologies, 2019, 16（1）: 30-39.
[23] SULIMOV V B, KUTOV D C, SULIMOV A V. Advances in docking[J]. Current Medicinal Chemistry, 2020, 26（42）: 7 555-7 580.
[24] LUO D D, HOU D R, WEN T C, et al. Efficacy and safety of Brucea javanica oil emulsion for liver cancer: A protocol for systematic review and meta-analysis[J]. Medicine, 2020, 99（47）: e23197.
[25] WANG C Z, YUAN C S. Potential role of ginseng in the treatment of colorectal cancer[J]. American Journal of Chinese Medicine, 2008, 36（6）: 1 019-1 028.
[26] 唐光甫, 桂艳玲, 满海乔, 等. 红曲桔霉素致毒机理的网络药理学分析[J]. 食品与生物技术学报, 2023, 42（2）: 90-96.
TANG G C, GUI Y L, MAN H Q, et al. Network pharmacology analysis of the toxic mechanism of red yeastcitrinin[J]. Journal of Food and Biotechnology, 2023, 42（2）: 90-96.
[27] 黄秋颜, 李斌, 林晓蓉, 等. 基于高分辨质谱和网络药理学的可可茶多酚降血糖活性研究[J]. 食品与机械, 2023, 39（9）: 4-11.
HUANG Q Y, LI B, LIN X R, et al. Study on the hypoglycemic activity of cocoa tea polyphenols based on high-resolution mass spectrometry and network pharmacology[J]. Food & Machinery, 2023, 39（9）: 4-11.